Michael Skynner
Technik-/Wissenschafts-/F&E-Leiter bei BICYCLE THERAPEUTICS PLC
Vermögen: 2 Mio $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Michael Skynner
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
78
| Public Company | Pharmaceuticals: Major | 78 |
Public Company | Biotechnology | 35 | |
Bicycle Therapeutics, Inc.
Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bicycle Therapeutics Plc, Bicycle Therapeutics, Inc. develops medicines and therapeutics for cancer treatment. The company is based in Lexington, MA. The company was founded in 2009 by Kevin Lee. Kevin Lee has been the CEO since 2009.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Cambridge Biotechnology Ltd.
Cambridge Biotechnology Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Biotechnology Ltd. is a wholly owned subsidiary of Biovitrum AB. The company's founders originate from a Pfizer Global Research & Development drug discovery team in what had previously been the Parke-Davis Neuroscience Research Centre. The founders, together with some key academic collaborators, created the company to exploit several opportunities in drug discovery as well as their world class 'gene to lead' drug discovery capability. The company has well equipped modern laboratory and office facilities situated on the Babraham Research Campus. This location allows the company to forge links with a host of world class research groups based in the Cambridge area. CBT is always looking to identify potential partner companies for both in-licensing and risk-sharing drug discovery ventures.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michael Skynner
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
University of Cambridge | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
BicycleTx Ltd.
BicycleTx Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2017, part of Bicycle Therapeutics Plc, BicycleTx Ltd. provides business support services. The company is based in Babraham, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
University of Oxford | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal Chief Executive Officer Investor Relations Contact | |
University of Pennsylvania | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
McGill University | College/University | Masters Business Admin Undergraduate Degree Doctorate Degree Doctorate Degree | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Consultant / Advisor | |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | General Counsel Director/Board Member Corporate Officer/Principal | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
University of Notre Dame | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ICON PUBLIC LIMITED COMPANY | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
ODONATE, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
University of California, Berkeley | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
Stanford University | College/University | Doctorate Degree President Doctorate Degree | |
POXEL | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Alchemab Therapeutics Ltd.
Alchemab Therapeutics Ltd. BiotechnologyHealth Technology Alchemab Therapeutics Ltd. engages in developing of antibodies. It focuses on discovering and developing novel therapeutics for patients. The company was founded in 2019 and is headquartered in Kings Cross, the Unite Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Medical Specialties | Director/Board Member Chairman | |
The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree Undergraduate Degree | |
Polyprox Therapeutics Ltd.
Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Polyprox Therapeutics Ltd. operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases. The company was founded by Laura S. Itzhaki in 2018 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
University of California San Diego | College/University | Undergraduate Degree Doctorate Degree | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Ipsen Bioinnovation Ltd.
Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
Fairleigh Dickinson University | College/University | Masters Business Admin Masters Business Admin | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin Undergraduate Degree | |
BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal Public Communications Contact | |
SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Washington University in St. Louis | College/University | Undergraduate Degree Graduate Degree | |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman Chief Operating Officer | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
TESARO INC | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
National Association of Corporate Directors
National Association of Corporate Directors Miscellaneous Commercial ServicesCommercial Services The National Association of Corporate Directors is a non-profit organization that provides essential resources to help directors strengthen board leadership. The American company was founded by Maryann Bruce and the CEO is Peter R. Gleason. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
University of Bath | College/University | Undergraduate Degree Graduate Degree | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Nuvaira, Inc.
Nuvaira, Inc. Electronic Equipment/InstrumentsElectronic Technology Nuvaira, Inc. develops medical devices for treating lung diseases. It works on a novel catheter-based system that has the potential to improve lung function, exercise capacity and quality of life for patients with chronic obstructive pulmonary disease. The company was founded by Steven Dimmer and Martin L. Mayse in 2008 and is headquartered in Plymouth, MN. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
JUNO THERAPEUTICS INC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 34 |
Vereinigtes Königreich | 15 |
Kanada | 2 |
Irland | 2 |
Frankreich | 2 |
Sektoral
Health Technology | 24 |
Consumer Services | 20 |
Commercial Services | 5 |
Finance | 4 |
Electronic Technology | 2 |
Operativ
Director/Board Member | 437 |
Corporate Officer/Principal | 266 |
Independent Dir/Board Member | 126 |
Undergraduate Degree | 81 |
Chief Executive Officer | 73 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Pierre Legault | 45 |
Amy Schulman | 45 |
Stephen J. Hoffman | 33 |
Kate Bingham | 31 |
Deborah Harland | 27 |
James Sutcliffe | 26 |
Marc Tessier-Lavigne | 24 |
Jason Rhodes | 24 |
Jose-Carlos Gutiérrez-Ramos | 24 |
Bosun Hau | 23 |
Olivier Brandicourt | 23 |
Andrew Peter Sandham | 22 |
John Hubbard | 20 |
Janice Bourque | 19 |
Martine George | 18 |
- Börse
- Insiders
- Michael Skynner
- Unternehmensverbindungen